Sarcopenia Clinical Trial
— FUNNEL+Official title:
Effectiveness of a Cardiac Rehabilitation Program on Biomechanical, Imaging, and Physiological Biomarkers in Elderly Patients With Heart Failure.
NCT number | NCT05393362 |
Other study ID # | Funnel+ Study |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | March 7, 2023 |
Est. completion date | March 2025 |
The main objective of the study is to assess the effectiveness of a cardiac rehabilitation program on functionality, measured by kinematic analysis, cardiorespiratory capacity, and ventricular ejection fraction in elderly patients with heart failure (HF). Other objectives will be; 1) to validate the kinematic analysis as an objective functional assessment that allows performing a functional stratification based on the severity of impairment ("kinematic phenotypes"), as well as to identify those patients who responders or are not responders to the cardiac rehabilitation program; 2) to develop a functional index that includes objective functional parameters, biomechanical biomarkers (heart and musculoskeletal echography) and physiological biomarkers (maximum consumption of oxygen (VO2 max), maximum heart rate (HR max) and blood lactate levels; 3) to analyse the degree of concordance of biomechanical biomarkers with functional tests normally used in clinical practice and with imaging and physiological biomarkers. A randomized, controlled, crossover clinical trial will be carried out at the Hospital Regional Universitario de Málaga. Clinically stable HF patients ≥70 years old will be included. The cardiac rehabilitation program will last 12 weeks and will follow the recommendations of the European Association of Cardiovascular Prevention and Rehabilitation. The patients will perform different functional tests, which will be at baseline, at 3 months and 6 months of follow-up.
Status | Recruiting |
Enrollment | 126 |
Est. completion date | March 2025 |
Est. primary completion date | December 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 70 Years and older |
Eligibility | Inclusion Criteria: - Subjects older than 70 years. - Subjects diagnosed with Heart Failure (HF) followed by the Heart Failure Unit. - Subjects will be able or filling out questionnaires and perform functional tasks; - Clinical stability. - Patients receive optimal treatment. Exclusion Criteria: - Participants with cardiac pathologies that do not have an HF situation - Score on the NYHA scale equal to 4. - Hospitalization in a period of time equal to or less than 3 months. - Score on the Mini-Mental scale (MMSE) below 24. - Inability to get up from the chair at least 5 times - Inability to walk. - Inability to walk independently without a gait assist device (cane, crutch, or walker). - Participation in an experimental study where they receive treatment. - Inability to provide informed consent. |
Country | Name | City | State |
---|---|---|---|
Spain | Antonio Cuesta Vargas | Málaga |
Lead Sponsor | Collaborator |
---|---|
University of Malaga |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Sociodemographic variables | Instruments: questionnaire, interview.
Measure: Age Gender Civil Status Educational Level |
Baseline | |
Other | Anthropometric variables_ Height | Instruments: Weighing machine, measuring tape, calculator Measure: height (cm) | Baseline | |
Other | Anthropometric variables_ Weight | Instruments: Weighing machine, measuring tape, calculator Measure: Weight (Kg) | Baseline | |
Other | Anthropometric variables_Body Mass Index (BMI). | Instruments: Weighing machine, measuring tape, calculator Measure: body mass index (BMI). | Baseline | |
Other | Clinical Variables_Comorbidities | Measure: Comorbidities, specifying number and types Instruments: Comorbidity Index of Charlson | Baseline | |
Other | Clinical Variables_Medication | Measure: Medication (specifying number of drugs and types), | Baseline | |
Other | Clinical Variables_ Characteristics of the heart failure (HF)_NYHA | Measure: Characteristics of the heart failure (HF) -main cause (ischemic/non-ischemic) Instruments: Grade of the New York Heart Association (NYHA) and symptom score from the Kansas-City questionnaire | Baseline | |
Other | Clinical Variables_Hospitalizations in the last 12 months | Measure: Hospitalizations in the last 12 months (number and reason: any cause/HF decompensated), | Baseline | |
Other | Clinical Variables_Consultation in the emergency department in the last 12 months | Measure: Consultation in the emergency department in the last 12 months (number and reason: any cause/decompensated HF) | Baseline | |
Other | Clinical Variables_Number of falls in the last 12 months | Measure: Number of falls in the last 12 months | Baseline | |
Other | Clinical Variables_ Characteristics of the heart failure (HF)_Kansas-City Questionnaire | Measure: Characteristics of the heart failure (HF) -main cause (ischemic/non-ischemic) Instruments: symptom score from the Kansas-City questionnaire | Baseline | |
Other | Clinical Variables_Toxic habits | Measure: toxic habits (tobacco, alcohol...). | Baseline | |
Primary | Physiological biomarkers_Cardiopulmonary Exercise Testing (CPET)-(Peak VO2) | Instruments: Cardiopulmonary Exercise Testing at Ciclo-ergometer Measure: the maximum volume of oxygen intake [VO2,(ml/kg/min)] | Baseline | |
Primary | Physiological biomarkers_Cardiopulmonary Exercise Testing (CPET)-(Peak VO2) | Instruments: Cardiopulmonary Exercise Testing at Ciclo-ergometer Measure: the maximum volume of oxygen intake [VO2,(ml/kg/min)] | Post intervention_difference (12 weeks after baseline) | |
Primary | Physiological biomarkers_Cardiopulmonary Exercise Testing (CPET)-(Peak VO2) | Instruments: Cardiopulmonary Exercise Testing at Ciclo-ergometer Measure: the maximum volume of oxygen intake [VO2,(ml/kg/min)] | Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Bioelectrical Impedance Analysis (BIA)- (PhA) | Instrument: Nutrilab Bioimpedance device (Akern 2016 with Biatrodes, Akern electrodes) Bioelectrical Phase Angle (PhA) - as derived from equations related to the parameters of BIVA - recently surged as a possible biomarker for patients with HF. Studies provided data about the application of PhA in the clinical management and in the overall risk stratification of HF patients. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Bioelectrical Impedance Analysis (BIA)- (R) | Instrument: Nutrilab Bioimpedance device (Akern 2016 with Biatrodes, Akern electrodes) Resistance (R, in Ohm)- is related to the amount of body fluids in the sum of intra- (ICW) and extracellular (ECW) water. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Bioelectrical Impedance Analysis (BIA)- (Xc) | Instrument: Nutrilab Bioimpedance device (Akern 2016 with Biatrodes, Akern electrodes) Reactance (Xc, in Ohm)-is mainly linked to the inner characteristics of the cell membranes. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Bioelectrical Impedance Analysis (BIA)- (FFM) | Instrument: Nutrilab Bioimpedance device (Akern 2016 with Biatrodes, Akern electrodes) Fat-free mass (FFM, kg)- represents the sum of bone mineral content (BMC) and total lean tissue measurements. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Bioelectrical Impedance Analysis (BIA)- (FM) | Instrument: Nutrilab Bioimpedance device (Akern 2016 with Biatrodes, Akern electrodes) Fat mass (FM, Kg) - is the total weight of the body minus the weight of any fat measured. This gives an indication of the water, bone, skin, and internal organs as a combined weight. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Bioelectrical Impedance Analysis (BIA)- (BCM) | Instrument: Nutrilab Bioimpedance device (Akern 2016 with Biatrodes, Akern electrodes) Body cell mass (BCM,Kg) -is the metabolically active cell mass involved in O2 consumption, CO2 production and energy expenditure. BCM measurement has been suggested as a tool for the evaluation of nutritional status. Since BCM is closely related to energy expenditure, it could also represent a good reference value for the calculation of nutrient needs | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Bioelectrical Impedance Analysis (BIA)- (ECW) | Instrument: Nutrilab Bioimpedance device (Akern 2016 with Biatrodes, Akern electrodes) Extracellular water (ECW, L/m) - is the aqueous component that surrounds cells and reflects clinical status in patients with acute or chronic diseases. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Bioelectrical Impedance Analysis (BIA)- (TBW) | Instrument: Nutrilab Bioimpedance device (Akern 2016 with Biatrodes, Akern electrodes) Total body water (TBW, L/m)- is integral to clinical care. It has significant implications for patient care that include the dosing of medications, assessment and treatment of dehydration, fluid, and energy requirements for parenteral nutrition, and dialysis prescriptions. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Bioelectrical Impedance Analysis (BIA)- (ECW/TBW) | Instrument: Nutrilab Bioimpedance device (Akern 2016 with Biatrodes, Akern electrodes) Extracellular Water/Total Body Water Analysis (ECW/TBW)-ratio of Extracellular Water(ECW) to Total Body Water(TBW); an important indicator of body water balance. In a healthy state, ECW/TBW ratio should fall within the range 0.360 to 0.390 | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Spirometric assessment-(TV) | Instrument: Spirometry device (Spiro USB and MicroRPM, Micro Medical) Tidall Volume (TV)-the amount of air moved in a normal inspiration or exhalation [TV,(mL/Kg)]. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Spirometric assessment-(VC) | Instrument: Spirometry device (Spiro USB and MicroRPM, Micro Medical) Vital Capacity (VC)-The amount of air that is moved in a maximal unforced inspiration or expiration. [VC,(L)]. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Spirometric assessment-(IRV) | Instrument: Spirometry device (Spiro USB and MicroRPM, Micro Medical) Inspiratory reserve volume(IRV)-Difference between the maximum volume that can be breathed in during a normal breath and in a maximal breath [IRV,(L)]. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Spirometric assessment-(ERV) | Instrument: Spirometry device (Spiro USB and MicroRPM, Micro Medical) Inspiratory reserve volume(IRV)-Difference between the maximum volume that can be exhaled in a normal breath and in a maximal breath [ERV,(L)]. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Spirometric assessment-(IC) | Instrument: Spirometry device (Spiro USB and MicroRPM, Micro Medical) Inspiratory Capacity (IC)-The amount of air that can be breathed in after a normal exhalation [IC,(L)]. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Spirometric assessment-(FVC) | Instrument: Spirometry device (Spiro USB and MicroRPM, Micro Medical) Forced Vital Capacity (FVC)-The amount of air moved in a maximal forced inspiration or expiration [FVC,(%)]; [FVC,(L)]. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Spirometric assessment-(FEV1) | Instrument: Spirometry device (Spiro USB and MicroRPM, Micro Medical) Forced Espiratory Volume1, (FEV1)-The amount of air moved in the first second of a forced exhalation; [FEV1,(mL/seg)]. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Spirometric assessment-(PEF) | Instrument: Spirometry device (Spiro USB and MicroRPM, Micro Medical) Peak Espiratory Flow, (PEF)-The maximum amount of air that can be exhaled per second in a forced exhalation.[PEF,(mL/seg)]; [PEF,(%)] | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Spirometric assessment-(MIP) | Instrument: Spirometry device (Spiro USB and MicroRPM, Micro Medical) Maximal inspiratory pressure(MIP)-the pressure generated during maximal inspiratory effort against a closed system.[MIP,(cm H2O)] | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Spirometric assessment-(MEP) | Instrument: Spirometry device (Spiro USB and MicroRPM, Micro Medical) Maximal Espiratory Pressure (MEP)-the pressure generated during maximal espiratory effort against a closed system.[MEP,(cm H2O)] | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Dynamometric assesment-(MDR-Hd-sEMG) | Instrument: High-Density electromyography device (HDEMG) (64-channel EMG amplifier; OT Bioelettronica+) Mean Discharge Rate of Tibialis Anterior Motor Units [MDR-Hd-sEMG,(Hz)]. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Dynamometric assesment-(VC-Hd-sEMG) | Instrument: High-Density electromyography device (HDEMG) (64-channel EMG amplifier; OT Bioelettronica+) Speed of propagation of Tibialis Anterior Motor Units [VC-Hd-sEMG,(m/s)]. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Dynamometric assesment- (F-Iso-FD-din) | Instrument: Dynamometer (J Tech Medical, Powertrack II Commander) Isometric strength in dorsiflexion of the ankle in both limbs during a 5-second maximal test using a digital hand-held dynamometer [F-Iso.FD-din,(N)]. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Dynamometric assesment- (F-Iso-FD-S) | Instrument: S-Type load cell (Biometrics Ltd) Isometric strength in dorsiflexion of the ankle in both limbs tests using S-Type load cell. The signal shall be analysed and processed using the required software. [F-Iso.FD-S]. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Dynamometric assesment-Timed Up and Go (TUG) | Instruments: a long corridor, a chair, a cone and a chronometer Measure: Time (seg) it takes to get up from a chair, walk 3 meters, turn around, return to the chair and sit down again. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Dynamometric assesment-Six minute walk test (6-MWT) | Instruments: a long corridor and a chronometer Measure: Evaluate the distance (m) a participant can walk for 6 minutes. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Dynamometric assesment-Short Physical performance Battery (SPPB) | Instruments: a long corridor, a chair, and a chronometer Measure: A set of short tests that time the time it takes to cover a short distance (4 m), repeat 5 times sit-stand up from the chair, and a set of balance tests (feet together, semi-tandem, and tandem). The end result is a score. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Metabolic biomarkers_Blood lactate | Instruments: Lactate Pro 2 Blood Lactate Analyzer Measure. Blood lactate (mmol/L) | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Cardiopulmonary Exercise Testing (CPET)-(Peak HR) | Instruments: Cardiopulmonary Exercise Testing at Ciclo-ergometer Measure: Peak of Heart Rate [Peak HR,(bpm)]. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Cardiopulmonary Exercise Testing (CPET)-(HRR) | Instruments: Cardiopulmonary Exercise Testing at Ciclo-ergometer Measure: Heart Rate Reserve (HRR)- the difference between the predicted maximal heart rate and the heart rate measured in VO2peak. [HRR,(bpm)]. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Cardiopulmonary Exercise Testing (CPET)-(VO2-VT1) | Instruments: Cardiopulmonary Exercise Testing at Ciclo-ergometer Measure: Ventilatory threshold oxygen consumption (VO2-VT1)- submaximal parameter of cardiorespiratory fitness [VO2-VT1,(mL/min)] | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Cardiopulmonary Exercise Testing (CPET)-(VO2/HR,O2 pulse) | Instruments: Cardiopulmonary Exercise Testing at Ciclo-ergometer Measure: Oxygen pulse [O2 pulse] is the ratio between VO2 (mLO2/min) and heart rate (HR - bpm). | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Cardiopulmonary Exercise Testing (CPET)-(CRE) | Instruments: Cardiopulmonary Exercise Testing at Ciclo-ergometer Measure: Chronotropic Response to Exercise (CRE)-percentage of the chronotropic index [CRE,(%)] | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Cardiopulmonary Exercise Testing (CPET)- (OUES) | Instruments: Cardiopulmonary Exercise Testing at Ciclo-ergometer Measure: Oxygen uptake efficiency slope (OUES)- the ratio of VO2 to the logarithm in base 10 of VE. OUES can be extracted from submaximal tests. [OUES] | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Cardiopulmonary Exercise Testing (CPET)-(RER) | Instruments: Cardiopulmonary Exercise Testing at Ciclo-ergometer Measure: The respiratory exchange ratio [RER] is the ratio of VCO2/VO2 | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Cardiopulmonary Exercise Testing (CPET)-(PeakW) | Instruments: Cardiopulmonary Exercise Testing at Ciclo-ergometer Measure: Peak W (Peak work rate)- highest work rate achieved during a maximum of 30 seconds during a stress test [PeakW,(W/min)]. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Cardiopulmonary Exercise Testing (CPET)-(?VO2/?WR) | Instruments: Cardiopulmonary Exercise Testing at Ciclo-ergometer Measure: [?VO2/?WR] Relationship. It is defined as the relationship between VO2 (Y-axis in mL.min-1) and workload (X-axis in Watts), measured only during exercise on a cycle ergometer with ramp protocol, whose value is progressively and linearly incremented until maximal effort. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Cardiopulmonary Exercise Testing (CPET)-(PeakVE) | Instruments: Cardiopulmonary Exercise Testing at Ciclo-ergometer Measure: Peak Pulmonary Ventilation (PeakVE)- highest volume of air moved in and out of the lung [PeakVE,(L/min)] | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Cardiopulmonary Exercise Testing (CPET)-(Vd/Vt) | Instruments: Cardiopulmonary Exercise Testing at Ciclo-ergometer Measure: Physiologic dead space over tidal volume (Vd/Vt) - a routine measurement, expressing the ratio of dead-space ventilation (VD) to tidal ventilation (VT) | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Cardiopulmonary Exercise Testing (CPET)-(VE/MVV) | Instruments: Cardiopulmonary Exercise Testing at Ciclo-ergometer Measure: Breathing reserve [VE/MVV] represents the ratio between maximal ventilation during exercise (VE) and maximum voluntary ventilation (MVV) at rest, both variables in L/min. | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Cardiopulmonary Exercise Testing (CPET)-(PETCO2) | Instruments: Cardiopulmonary Exercise Testing at Ciclo-ergometer Measure: End-tidal CO2 partial pressure [PETCO2, (mmHg)] | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Cardiopulmonary Exercise Testing (CPET)-(PETO2) | Instruments: Cardiopulmonary Exercise Testing at Ciclo-ergometer Measure: End-tidal O2 partial pressure [PETO2, (mmHg)] | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Cardiopulmonary Exercise Testing (CPET)-(VE/VCO2) | Instruments: Cardiopulmonary Exercise Testing at Ciclo-ergometer Measure: Ventilatory equivalents for oxygen [VE/VO2], the ratios between pulmonary ventilation and CO2 production(VE/VCO2) | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers _Cardiopulmonary Exercise Testing (CPET)-(VE/VO2) | Instruments: Cardiopulmonary Exercise Testing at Ciclo-ergometer Measure: Ventilatory equivalents for oxygen [VE/VO2], the ratios between pulmonary ventilation and O2 consumption (VE/VO2) | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_hematocrit | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: hematocrit (%) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_hemoglobin | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: hemoglobin 1AC, blood (%) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_Mean Corpuscular Volume (MCV) | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: mean corpuscular volume [MCV,(fL)] |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_Mean Corpuscular Hemoglobin (MCH) | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: mean corpuscular hemoglobin [MCH,(pg)] |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_Mean Corpuscular Hemoglobin Concentration (MCHC) | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: mean corpuscular hemoglobin [MCHC,(g/dL)] |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_Leukocytes | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: leukocytes (mg/dL) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_Platelet count | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: platelet count (units/mcL) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_Glomerular Filtration Rate (GFR) | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: glomerular filtration rate [GFR, (mL/min/1.73m²)] |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_Creatinine | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: creatinine (mg/dL) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_Glucose | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: glucose (mmol/L) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_Uric Acid | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: uric acid (mg/dL) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_sodium, potassium, calcium | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: sodium, potassium, and calcium (mmol/L) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_transaminases -ALT, AST, GGT, FA | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure:transaminases Aminotransferase, alanine [ALT, (U/L)] Aminotransferase, aspartate [AST,(U/L)] Gamma-glutamyl transpeptidase [GGT,(U/L)] Alpha fetoprotein[FA,(mcg/L)] |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_glycated hemoglobin | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: glycated hemoglobin (mmol/mol) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_ferritin | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: ferritin (ng/mL) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_iron | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: iron (mcg/dL) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_Index of transferrin saturation | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: index of transferrin saturation (%) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_transferrin | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: transferrin (mg/dL) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_ vitamin B12 | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: vitamin B12 (pg/mL) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_ folic acid | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: folic acid (ng/mL) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_ HDL | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: High-density lipoprotein [HDL,(mg/dL)] |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_ TSH | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: TSH (mclU/mL) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_ Total cholesterol (TC) | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: total cholesterol [TC,(mg/dL)] |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_ LDL | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: Low-density lipoprotein [LDL,(mg/dL)] |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_ albumin | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: albumin (g/dL) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_ triglycerides | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: triglycerides (mg/dL9 |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_ NT-proBNP | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure:N-Terminal propeptide of BNP[NT-proBNP,(pg/mL)] |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Physiological biomarkers_Blood biomarkers_ Complete Blood Cell Count (CBC)_ vitamin D. | Instruments: The blood test. The extraction of the blood sample must be carried out by a qualified professional (Physician or Nurse). For data analysis, the samples will be sent to the laboratory to recounter de sample.
Measure: vitamin D (ng/ml) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Biomechanical biomarkers _ RGB-D camera (depth camera)_Trunk linear acceleration | Instruments: RGB-D camera or depth camera. Kinematic analysis by 3D motion capture.
Measure: Trunk linear acceleration (m/s2) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Biomechanical biomarkers_ RGB-D camera (depth camera)_Trunk angular displacement | Instruments: RGB-D camera or depth camera. Kinematic analysis by 3D motion capture.
Measure: Trunk angular displacement (°) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Biomechanical biomarkers _ RGB-D camera (depth camera)_Trunk angular velocity | Instruments: RGB-D camera or depth camera. Kinematic analysis by 3D motion capture.
Measure: Trunk angular velocity (°/s) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Biomechanical biomarkers_ Shimmer3_Step and stride length | Instruments: Inertial sensor (Accelerometer, Gyroscope, and Magnetometer) included in the Shimmer3 instrument.
Measure: Step and stride length |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Biomechanical biomarkers_ Shimmer3_Step and stride time | Instruments: Inertial sensor (Accelerometer, Gyroscope, and Magnetometer) included in the Shimmer3 instrument.
Measure: Step and stride time (seg) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Biomechanical biomarkers _ Shimmer3_Step and stride widths stride | Instruments: Inertial sensor (Accelerometer, Gyroscope, and Magnetometer) included in the Shimmer3 instrument.
Measure: Step and stride widths stride |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Biomechanical biomarkers _ Shimmer3_Swing phase time gait | Instruments: Inertial sensor (Accelerometer, Gyroscope, and Magnetometer) included in the Shimmer3 instrument.
Measure: Swing phase time gait |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Biomechanical biomarkers _ Shimmer3_Gait speed (m/s) | Instruments: Inertial sensor (Accelerometer, Gyroscope, and Magnetometer) included in the Shimmer3 instrument.
Measure: Gait speed (m/s) |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Biomechanical biomarkers _ Shimmer3_Stance phase | Instruments: Inertial sensor (Accelerometer, Gyroscope, and Magnetometer) included in the Shimmer3 instrument.
Measure: Stance phase |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Biomechanical biomarkers _ Shimmer3_Step speed and stride. | Instruments: Inertial sensor (Accelerometer, Gyroscope, and Magnetometer) included in the Shimmer3 instrument.
Measure: Step speed and stride. |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Biomechanical biomarkers _ Shimmer3_Step symmetry | Instruments: Inertial sensor (Accelerometer, Gyroscope, and Magnetometer) included in the Shimmer3 instrument.
Measure: Step symmetry |
Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Imaging biomarkers _Cardiac-Echocardiogram (LVEF) | Instruments: Echocardiogram Measure:Left ventricular Ejection Fraction (%), LVEF | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Imaging biomarkers _Cardiac-Echocardiogram (Dilatation and Diameter of the left atrium and left ventricle) | Instruments: Echocardiogram Measure: Dilatation of the left atrium, Dilatation of the left ventricle, Diameter of the left atrium, Diameter of the left ventricle (cm) | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Imaging biomarkers _Muscular-Echocardiographic (Muscle Thickness) | Instruments: B-mode ultrasonography device (SonoSite 180 Plus, SonoSite Japan, Tokyo, Japan) Measure: Muscular thickness of the quadriceps rectus muscle ,the diaphragm muscle thickness obtained at the end of inspiration (at total lung capacity; DT-insp) and at resting expiration (at functional residual capacity; DT-exp) through Matlab software (CodigoEco)-[Muscle Thickness] | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Imaging biomarkers _Displacement-Echocardiographic (Slide-pL) | Instruments: B-mode ultrasonography device (SonoSite 180 Plus, SonoSite Japan, Tokyo, Japan) Measure: Pleural displacement (Slide-pL, mm) during a complete respiratory cycle through Matlab software (CodigoEco)-[Slide-pL] | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Imaging biomarkers_Muscular-Echocardiographic (Fat Thickness) | Instruments: B-mode ultrasonography device (SonoSite 180 Plus, SonoSite Japan, Tokyo, Japan) Measure: Fat thickness of the quadriceps rectus muscle through Matlab software (CodigoEco)-[Fat Thickness] | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Imaging biomarkers_Muscular-Echocardiographic (Muscle Echo-Intensity) | Instruments: B-mode ultrasonography device (SonoSite 180 Plus, SonoSite Japan, Tokyo, Japan) Measure: Muscle Echo-intensity of the quadriceps rectus muscle through Matlab software (CodigoEco)- [Muscle His] | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Imaging biomarkers_Muscular-Echocardiographic (Fat Echo-Intensity) | Instruments: B-mode ultrasonography device (SonoSite 180 Plus, SonoSite Japan, Tokyo, Japan) Measure: Fat Echo-intensity of the quadriceps rectus muscle through Matlab software (CodigoEco)- [Fat His] | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Self-reported_ Borg Rating of Perceived Exertion (RPE)-Borg Scale | Instruments: Borg Rating of Perceived Exertion (RPE)- Borg Scale Measure: The Borg Rating of Perceived Exertion (RPE) is a way of measuring physical activity intensity level. Perceived exertion is how hard you feel like your body is working. It is based on the physical sensations a person experiences during physical activity, including increased heart rate, increased respiration or breathing rate, increased sweating, and muscle fatigue. Although this is a subjective measure, your exertion rating based on a 6 to 20 rating scale, may provide a fairly good estimate of your actual heart rate during physical activity | Baseline, Post-intervention (12 weeks after baseline) and Follow up (12 weeks after post-intervention) | |
Secondary | Self-reported_Sarcopenia Questionnaire (SARC-F) | Instruments: SARC-F questionnaire Measure: It is a simple questionnaire to rapidly diagnose Sarcopenia. It is composed by 5 components: Strength, Assistance to walk, Get up from a chair, Climb stairs and Falls. Scores range from 0 to 10, with 0 to 2 points for each component. A score equal to or greater than 4 could predict sarcopenia and poor results. | Baseline, Post-intervention (12 weeks after baseline) | |
Secondary | Self-reported_abbreviated Comprehensive Geriatric Assessment (aCGA): | Instruments: abbreviated Comprehensive Geriatric Assessment (aCGA): a questionnaire formed by items originating from four different scales.
Measure: 4 instruments such as: the Geriatric Depression Scale (GDS), the Mini-Mental State Examination (MMSE), Activities of Daily Living (ADL) using the Katz index and instrumental activities of daily living (IADL) using the Lawnton & Brody scale. The score varies from 0 to 30 points, giving 1 point to each of the items of the GDS (4 points in total), 12 to the 3 items from the scale of Lawton & Brody, 8 points to the 4 items from the MMSE and 6 points to the 3 items from the Katz index. |
Baseline, Post-intervention (12 weeks after baseline) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06287502 -
Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis
|
N/A | |
Recruiting |
NCT05063279 -
RELIEF - Resistance Training for Life
|
N/A | |
Completed |
NCT03644030 -
Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
|
||
Recruiting |
NCT06143592 -
Inspiratory Muscle Training on Balance, Falls and Diaphragm Thickness in the Elderly
|
N/A | |
Terminated |
NCT04350762 -
Nutritional Supplementation in the Elderly With Weight Loss
|
N/A | |
Enrolling by invitation |
NCT05953116 -
Managing the Nutritional Needs of Older Filipino With Due Attention to Protein Nutrition and Functional Health Study
|
N/A | |
Recruiting |
NCT04028206 -
Resistance Exercise or Vibration With HMB for Sarcopenia
|
N/A | |
Enrolling by invitation |
NCT03297632 -
Improving Muscle Strength, Mass and Physical Function in Older Adults
|
N/A | |
Completed |
NCT04015479 -
Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults
|
N/A | |
Completed |
NCT03234920 -
Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation After Liver Transplantation
|
N/A | |
Recruiting |
NCT03998202 -
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
|
||
Recruiting |
NCT04717869 -
Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty
|
||
Completed |
NCT05497687 -
Strength-building Lifestyle-integrated Intervention
|
N/A | |
Completed |
NCT03119610 -
The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity
|
Phase 1/Phase 2 | |
Recruiting |
NCT05711095 -
The Anabolic Properties of Fortified Plant-based Protein in Older People
|
N/A | |
Recruiting |
NCT05008770 -
Trial in Elderly With Musculoskeletal Problems Due to Underlying Sarcopenia - Faeces to Unravel Gut and Inflammation Translationally
|
||
Not yet recruiting |
NCT05860556 -
Sustainable Eating Pattern to Limit Malnutrition in Older Adults
|
||
Recruiting |
NCT04522609 -
Electrostimulation of Skeletal Muscles in Patients Listed for a Heart Transplant
|
N/A | |
Recruiting |
NCT04545268 -
Prehabilitation for Cardiac Surgery in Patients With Reduced Exercise Tolerance
|
N/A | |
Recruiting |
NCT03160326 -
The QUALITY Vets Project: Muscle Quality and Kidney Disease
|